SLC39A7 Promotes Malignant Behaviors in Glioma Via the TNF-α-mediated NF-κB Signaling Pathway

Overview

Journal J Cancer

Specialty Oncology

Date 2021 Jun 21

PMID 34149917

Citations 5

Authors

Lian Chen

Jinpeng Zhou

Long Li

JunShuang Zhao

Hao Li

Wei Zheng

Jinkun Xu

Zhitao Jing

Affiliations

Soon will be listed here.

Abstract

Several studies have indicated that SLC39A7 plays an important role in tumor progression; however, little is known about the function and mechanism of SLC39A7 in glioma. In this study, we aimed to explore the role of SLC39A7 in glioma development. Bioinformatic analysis was used to predict the role of SLC39A7 in glioma. Cell viability and Edu assays were used to detect the proliferation of glioma cells. A transwell assay was used to measure the invasion and migration of glioma cells. Western blotting, qPCR and ELISA were used to detect the expression of all molecules. SLC39A7 was found to be highly expressed in high-grade glioma patients with a poor prognosis. Our results indicated that SLC39A7 significantly promoted the proliferation, invasion and migration of glioma cells. Furthermore, SLC39A7 promoted tumorigenesis in orthotopic models. We determined that SLC39A7 promotes the malignant behaviors of glioma by activating the TNF-α-mediated NF-κB signaling pathway. Our study revealed that SLC39A7 promotes the proliferation, invasion and migration of glioma cells via the TNF-α-mediated NF-κB signaling pathway, which provides potential targets for glioma therapy.

Citing Articles

NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling.

Tong Q, Yan D, Cao Y, Dong X, Abula Y, Yang H Sci Rep. 2023; 13(1):11795.

PMID: 37479837 PMC: 10362011. DOI: 10.1038/s41598-023-38596-7.

The Recent Research Progress of NF-κB Signaling on the Proliferation, Migration, Invasion, Immune Escape and Drug Resistance of Glioblastoma.

Shi P, Xu J, Cui H Int J Mol Sci. 2023; 24(12).

PMID: 37373484 PMC: 10298967. DOI: 10.3390/ijms241210337.

Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation.

Vishnubalaji R, Abdel-Razeq H, Gehani S, Albagha O, Alajez N Int J Mol Sci. 2022; 23(18).

PMID: 36142814 PMC: 9506546. DOI: 10.3390/ijms231810901.

CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling.

Jiang Y, Zhao J, Liu Y, Hu J, Gao L, Wang H Cell Death Dis. 2022; 13(8):697.

PMID: 35945192 PMC: 9363451. DOI: 10.1038/s41419-022-05149-1.

The RNF26/CBX7 axis modulates the TNF pathway to promote cell proliferation and regulate sensitivity to TKIs in ccRCC.

Liu W, Wang H, Jian C, Li W, Ye K, Ren J Int J Biol Sci. 2022; 18(5):2132-2145.

PMID: 35342353 PMC: 8935234. DOI: 10.7150/ijbs.69325.

References

Kolenko V, Teper E, Kutikov A, Uzzo R . Zinc and zinc transporters in prostate carcinogenesis. Nat Rev Urol. 2013; 10(4):219-26. PMC: 3702371. DOI: 10.1038/nrurol.2013.43. View

Taylor K, Hiscox S, Nicholson R, Hogstrand C, Kille P . Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci Signal. 2012; 5(210):ra11. PMC: 3428905. DOI: 10.1126/scisignal.2002585. View

Taylor K, Vichova P, Jordan N, Hiscox S, Hendley R, Nicholson R . ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology. 2008; 149(10):4912-20. DOI: 10.1210/en.2008-0351. View

Kambe T, Yamaguchi-Iwai Y, Sasaki R, Nagao M . Overview of mammalian zinc transporters. Cell Mol Life Sci. 2004; 61(1):49-68. PMC: 11138893. DOI: 10.1007/s00018-003-3148-y. View

Ziliotto S, Gee J, Ellis I, Green A, Finlay P, Gobbato A . Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer. Metallomics. 2019; 11(9):1579-1592. PMC: 6796783. DOI: 10.1039/c9mt00136k. View

Ohashi W, Kimura S, Iwanaga T, Furusawa Y, Irie T, Izumi H . Zinc Transporter SLC39A7/ZIP7 Promotes Intestinal Epithelial Self-Renewal by Resolving ER Stress. PLoS Genet. 2016; 12(10):e1006349. PMC: 5065117. DOI: 10.1371/journal.pgen.1006349. View

Wei Y, Dong J, Li F, Wei Z, Tian Y . Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer. EXCLI J. 2017; 16:1165-1176. PMC: 5735344. DOI: 10.17179/excli2017-690. View

Hogstrand C, Kille P, Nicholson R, Taylor K . Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol Med. 2009; 15(3):101-11. DOI: 10.1016/j.molmed.2009.01.004. View

Fu M, Wang C, Hsieh Y, Fang K, Tzeng S . Functional Role of Matrix gla Protein in Glioma Cell Migration. Mol Neurobiol. 2017; 55(6):4624-4636. DOI: 10.1007/s12035-017-0677-1. View

10.

Sheng N, Yan L, You W, Tan G, Gong J, Chen H . Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells. Acta Biochim Biophys Sin (Shanghai). 2017; 49(10):926-934. DOI: 10.1093/abbs/gmx094. View

11.

Jiang Y, Zhou J, Luo P, Gao H, Ma Y, Chen Y . Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway. EBioMedicine. 2018; 37:78-90. PMC: 6286187. DOI: 10.1016/j.ebiom.2018.10.053. View

12.

Pozniak P, White M, Khalili K . TNF-α/NF-κB signaling in the CNS: possible connection to EPHB2. J Neuroimmune Pharmacol. 2013; 9(2):133-41. PMC: 3959244. DOI: 10.1007/s11481-013-9517-x. View

13.

Rajesh Y, Pal I, Banik P, Chakraborty S, Borkar S, Dey G . Insights into molecular therapy of glioma: current challenges and next generation blueprint. Acta Pharmacol Sin. 2017; 38(5):591-613. PMC: 5457688. DOI: 10.1038/aps.2016.167. View

14.

Zhang Y, Bai J, Si W, Yuan S, Li Y, Chen X . SLC39A7, regulated by miR-139-5p, induces cell proliferation, migration and inhibits apoptosis in gastric cancer via Akt/mTOR signaling pathway. Biosci Rep. 2020; 40(2). PMC: 7048674. DOI: 10.1042/BSR20200041. View

15.

Jiang Y, Zhou J, Hou D, Luo P, Gao H, Ma Y . Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway. J Pathol. 2019; 249(1):26-38. DOI: 10.1002/path.5278. View

16.

Beyersmann D, Haase H . Functions of zinc in signaling, proliferation and differentiation of mammalian cells. Biometals. 2002; 14(3-4):331-41. DOI: 10.1023/a:1012905406548. View

17.

St-Denis N, Litchfield D . Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell Mol Life Sci. 2009; 66(11-12):1817-29. PMC: 11115660. DOI: 10.1007/s00018-009-9150-2. View

18.

Stupp R, Lukas R, Hegi M . Improving survival in molecularly selected glioblastoma. Lancet. 2019; 393(10172):615-617. DOI: 10.1016/S0140-6736(18)33211-2. View

19.

Anzilotti C, Swan D, Boisson B, Deobagkar-Lele M, Oliveira C, Chabosseau P . An essential role for the Zn transporter ZIP7 in B cell development. Nat Immunol. 2019; 20(3):350-361. PMC: 6561116. DOI: 10.1038/s41590-018-0295-8. View

20.

Aldape K, Brindle K, Chesler L, Chopra R, Gajjar A, Gilbert M . Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019; 16(8):509-520. PMC: 6650350. DOI: 10.1038/s41571-019-0177-5. View